2026-03-27 中国科学院（CAS）
＜関連情報＞
- https://english.cas.cn/newsroom/research-news/202603/t20260327_1154067.shtml
- https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00157-1
肝細胞癌の初期悪性化における分子レベルでの知見 Molecular insights into early malignant transition of hepatocellular carcinoma
Zhengtao Zhang ∙ Hong Li ∙ Lingli Chen ∙ … ∙ Hui Dong ∙ Yuan Ji ∙ Lijian Hui
Cancer Cell Published:March 26, 2026
DOI:https://doi.org/10.1016/j.ccell.2026.03.005
Graphical abstract
Highlights
- TERT alterations may predispose dysplastic nodules (DNs) to malignant transition
- Copy number alterations account for malignant transition in HCC
- Arising from immune inactive DNs, veHCCs display immune surveillance and evasion
- Two potential major evolutionary scenarios are involved in HCC initiation
Summary
Understanding the molecular drivers of the premalignant-to-malignant transition is essential for early cancer detection and intervention, yet this process remains poorly characterized due to limited access to evolutionarily related lesions. Here, we comprehensively profiled the genomic and immunological landscapes of 21 very early hepatocellular carcinomas (veHCCs) arising within 17 cancer-prone dysplastic nodules (DNs). Notably, 82% of cancer-prone DNs harbored TERT alterations, suggesting a predisposing rather than causative role of TERT alteration in malignant transition. Notably, the accumulation of copy number alterations (CNAs), rather than single-nucleotide variants, is strongly associated with malignant transition. Intriguingly, different from the paradigm that HCC arises in chronic inflammation, cancer-prone DNs displayed immune inactivity. Strikingly, 43% of veHCCs showed an inflamed yet immune-evasive phenotype. These findings propose two evolutionary scenarios of early hepatocarcinogenesis, CNA-dominant progression and inflamed progression with early immune evasion, underscoring the potential of immunotherapy for early intervention.
